PIH Health, based in Whittier, Calif., is experiencing a network disruption that is affecting its operations, KABC reported Dec. 4.
Category: Static
Mark Cuban defends his disruption status
Experts in healthcare and the pharmaceutical industry have questioned Mark Cuban’s ability to puncture high-priced medicines. In a 90-minute fireside chat with one of his critics, Mr. Cuban said his company has “truly changed the game.”
Cancer risk and loneliness: 9 things to know
Experts are beginning to observe how the loneliness epidemic is influencing cancer rates and mortality in the U.S., according to analysis published Dec. 2 in Cancer Cytopathology.
Why this university is teaching advanced practice providers how to cook
Greenville, N.C.-based East Carolina University is piloting a program that adds cooking and nutrition classes to its physician assistant curriculum.
CVS Health to close Utah MinuteClinics
CVS Health has shared plans to close its three MinuteClinic locations in Utah by Dec. 7.
Addressing care gaps for cancer survivors
The oncology industry is continuing to study cancer survivorship and understand its role in patient care, according to a Dec. 3 Cancer Network report.
Healthcare workers urge state keep SUNY Downstate open
A coalition of healthcare workers and community advocates are urging New York Gov. Kathy Hochul to maintain inpatient services at University Hospital at Downstate in Brooklyn after the state shared plans in January to significantly reduce or potentiall…
The lingering effects of Ascension's cyberattack
Ascension reported a cyberattack on May 8 interrupting its IT systems and disrupting patient care. The system reverted to downtime procedures through mid-June, when the EHR was restored, but reverberations from the attack continue.
Change Healthcare readies for data breach settlement
Change Healthcare will soon meet with a federal judge to discuss a possible settlement agreement over the data breach that affected 100 million Americans.
Zepbound outperforms Wegovy for weight loss: Study
A new phase 3 clinical trial found that Eli Lilly’s weight loss drug Zepbound resulted in significantly greater weight loss than Wegovy.
